Empagliflozin (Jardiance): a novel SGLT2 inhibitor for the treatment of type-2 diabetes.
Empagliflozin ( Jardiance ) : a novel SGLT2 inhibitor for the treatment of type-2 diabetes .
Which protein does empagliflozin inhibit?
Which protein does empagliflozin inhibit ?
SGLT2
SGLT2